Publikationen von Christian Namendorf

Liu, X.; Novak, B.; Namendorf, C.; Steigenberger, B.; Zhang, Y.; Turck, C. W.: Long-lived proteins and DNA as candidate predictive biomarkers for tissue associated diseases. ISCIENCE 27 (4), 109642 (2024)

Wedel, S.; Hahnefeld, L.; Schreiber, Y.; Namendorf, C.; Heymann, T.; Uhr, M.; Schmidt, M. V.; de Bruin, N.; Hausch, F.; Thomas, D. et al.; Geisslinger, G.; Sisignano, M.: SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators. JOURNAL OF NEUROINFLAMMATION 20 (1), 149 (2023)

Spieler, D.; Namendorf, C.; Namendorf, T.; von Cube, M.; Uhr, M.: Donepezil, a cholinesterase inhibitor used in Alzheimer's disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice. JOURNAL OF PSYCHIATRIC RESEARCH 124, S. 29 - 33 (2020)

Spieler, D.; Namendorf, C.; Namendorf, T.; Uhr, M.: abcb1ab p-glycoprotein is involved in the uptake of the novel antidepressant vortioxetine into the brain of mice. JOURNAL OF PSYCHIATRIC RESEARCH 109, S. 48 - 51 (2019)

Engel, M.; Eggert, C.; Kaplick, P. M.; Eder, M.; Röh, S.; Tietze, L.; Namendorf, C.; Arloth, J.; Weber, P.; Rex-Haffner, M. et al.; Geula, S.; Jakovcevski, M.; Hanna, J. H.; Leshkowitz, D.; Uhr, M.; Wotjak, C. T.; Schmidt, M. V.; Deussing, J. M.; Binder, E. B.; Chen, A.: The Role of m⁶A/m-RNA Methylation in Stress Response Regulation. NEURON 99 (2), S. 389 - 403 (2018)

Balsevich, G.; Häusl, A. S.; Meyer, C. W.; Karamihalev, S.; Feng, X.; Pöhlmann, M.; Dournes, C.; Uribe-Marino, A.; Santarelli, S.; Labermaier, C. et al.; Hafner, K.; Mao, T.; Breitsamer, M.; Theodoropoulou, M.; Namendorf, C.; Uhr, M.; Páez-Pereda, M.; Winter, G.; Hausch, F.; Chen, A.; Tschoep, M. H.; Rein, T.; Gassen, N. C.; Schmidt, M. V.: Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function. NATURE COMMUNICATIONS 8, 1725 (2017)

Menke, A.; Arloth, J.; Best, J.; Namendorf, C.; Gerlach, T.; Czamara, D.; Lucae, S.; Dunlop, B. W.; Crowe, T. M.; Garlow, S. J. et al.; Nemeroff, C. B.; Ritchie, J. C.; Craighead, W. E.; Mayberg, H. S.; Rex-Haffner, M.; Binder, E. B.; Uhr, M.: Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests. PSYCHONEUROENDOCRINOLOGY 69, S. 161 - 171 (2016)

Auffenberg, E.; Jurik, A.; Mattusch, C.; Stoffel, R.; Genewsky, A.; Namendorf, C.; Schmid, R. M.; Rammes, G.; Biel, M.; Uhr, M. et al.; Moosmang, S.; Michalakis, S.; Wotjak, C. T.; Thoeringer, C. K.: Remote and reversible inhibition of neurons and circuits by small molecule induced potassium channel stabilization. SCIENTIFIC REPORTS 6, 19293 (2016)

Santarelli, S.; Namendorf, C.; Anderzhanova, E.; Gerlach, T.; Bedenk, B.; Kaltwasser, S.; Wagner, K.; Labermaier, C.; Reichel, J.; Drgonova, J. et al.; Czisch, M.; Uhr, M.; Schmidt, M. V.: The amino acid transporter SLC6A15 is a regulator of hippocampal neurochemistry and behavior. JOURNAL OF PSYCHIATRIC RESEARCH 68, S. 261 - 269 (2015)

Balsevich, G.; Namendorf, C.; Gerlach, T.; Uhr, M.; Schmidt, M. V.: The bio-distribution of the antidepressant clomipramine is modulated by chronic stress in mice: effects on behavior. Frontiers in behavioral neuroscience 8, 445 (2015)

Balsevich, G.; Namendorf, C.; Gerlach, T.; Uhr, M.; Schmidt, M. V.: The bio-distribution of the antidepressant clomipramine is modulated by chronic stress in mice: effects on behavior. FRONTIERS IN BEHAVIORAL NEUROSCIENCE 8, 445 (2015)

Gaali, S.; Kirschner, A.; Cuboni, S.; Hartmann, J.; Kozany, C.; Balsevich, G.; Namendorf, C.; Fernandez-Vizarra, P.; Sippel, C.; Zannas, A. S. et al.; Draenert, R.; Binder, E. B.; Almeida, O. F. X.; Ruehter, G.; Uhr, M.; Schmidt, M. V.; Touma, C.; Bracher, A.; Hausch, F.: Selective inhibitors of the FK506-binding protein 51 by induced fit. NATURE CHEMICAL BIOLOGY 11 (1), S. 33 - + (2015)

Hartmann, J.; Wagner, K. V.; Gaali, S.; Kirschner, A.; Kozany, C.; Ruhter, G.; Dedic, N.; Häusl, A. S.; Hoeijmakers, L.; Westerholz, S. et al.; Namendorf, C.; Gerlach, T.; Uhr, M.; Chen, A.; Deussing, J. M.; Holsboer, F.; Hausch, F.; Schmidt, M. V.: Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties. The Journal of neuroscience: the official journal of the Society for Neuroscience 35 (24), S. 9007 - 16 (2015)

Schmidt, M. V.; Trümbach, D.; Weber, P.; Wagner, K.; Scharf, S. H.; Liebl, C.; Datson, N.; Namendorf, C.; Gerlach, T.; Kühne, C. et al.; Uhr, M.; Deussing, J. M.; Wurst, W.; Binder, E. B.; Holsboer, F.; Müller, M. B.: Individual Stress Vulnerability Is Predicted by Short-Term Memory and AMPA Receptor Subunit Ratio in the Hippocampus. Journal of Neuroscience 30 (50), S. 16949 - 16958 (2010)

Kirschbaum, K. M.; Uhr, M.; Holthoewer, D.; Namendorf, C.; Pietrzik, C.; Hiemke, C.; Schmitt, U.: Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice. Neuropharmacology 59 (6), S. 474 - 479 (2010)

Uhr, M.; Tontsch, A.; Namendorf, C.; Ripke, S.; Lucae, S.; Ising, M.; Dose, T.; Ebinger, M.; Rosenhagen, M.; Kohli, M. et al.; Kloiber, S.; Salyakina, D.; Bettecken, T.; Specht, M.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.: Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression. Neuron 57, S. 203 - 209 (2008)

Uhr, M.; Namendorf, C.; Grauer, M. T.; Rosenhagen, M.; Ebinger, M.: P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6. Journal of Psychopharmacology 18 (4), S. 509 - 515 (2004)

Grauer, M. T.; Namendorf, C.; Ebinger, M.; Rippel, A.; Uhr, M.: Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls. Pharmacopsychiatry 36 (5), S. 228 - 229 (2003)

Ising, M.; Belcredi, P.; Lucae, S.; Tontsch, A.; Namendorf, C.; Uhr, M.; Holsboer, F.; Rex-Haffner, M.; Simulionyte, E.; Hebib, S. et al.; Gruber Oliver, O.; Behler, N.; Nenov-Matt, T.; Schuele, C.; Manook, A.; Heckel, B.; Baghai, T.; Rupprecht, R.: GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, S. i314 - i314. (2025)